Primer: Ionetix (IONTX US) - Aug 2026
Ionetix is a vertically integrated radiopharmaceutical company with a unique competitive advantage in its proprietary superconducting cyclotron...
Ionetix (IONTX US): Synthetic Expert Call Transcript (10 Aug 2026)
Cardiac PET Market Realities: While N-13 Ammonia has superior clinical performance, its 10-minute half-life forces a decentralized, on-site...
IPO Databook: Ionetix (US) - Aug 2026
Ionetix Corporation develops superconducting cyclotron technology for medical and industrial applications, generating revenue from diagnostic and...
No more insights